EudraVigilance - EVWEB User Manual
EudraVigilance also provides advice on the measures to ensure the safe and ... (i.e. the pre- and post-authorisation phase). These processes include clinical studies, reports of spontaneous adverse reactions, events, regulatory submissions and regulated product information.
Download EudraVigilance - EVWEB User Manual
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Application to extend or shorten a time limit or for ...
www.qcat.qld.gov.auCredit card payments can be made by submitting a Credit card payment authorisation form with your application and can only be accepted by post or in person. You may apply to QCAT for a waiver of the fee on the grounds of financial hardship.
The linguistic review process of product information in ...
www.ema.europa.eu3. The linguistic review process for post-authorisation procedures Detailed practical information regarding product information submission is available in the Agency Post-Authorisation Procedural Advice on the European Medicines Agency website. The same general principles as for the post-opinion linguistic review of New Applications apply, as
Government of India - India Post
www.indiapost.gov.in3.08 Post Office Balances 24 3.09 Balances of abolished HPO 24 3.10 CGA Report for March 24 3.11 Due dates of completion of CGA Abstract 24 3.12 Disposal of documents, vouchers, bills etc received from DDOs 25 3.13 Duties of Accountants in PA Sections 25 3.14 Role of Accountant – Post PFMS Data submission 28